1 MILLION PATIENTS 

ON THERAPY ACROSS APPROVED
CONDITIONS WORLDWIDE*

*The worldwide patient number is largely represented by 10 countries and includes patients on therapy for these uses approved in the US: AD, asthma, CRSwNP, PN, EoE, and COPD.

THINGS TO KNOW
ABOUT DUPIXENT

HELPS REDUCE A KEY
SOURCE OF INFLAMMATION

NOT A STEROID OR AN
IMMUNOSUPPRESSANT

CAN CONTINUOUSLY WORK
EVEN IN BETWEEN DOSES

Dupixent MyWay® Copay Card

AS LITTLE AS $0* COPAY
MAY BE AVAILABLE

With the DUPIXENT MyWay® Copay Card, eligible patients with commercial health insurance may pay as little as $0* in copay per fill of DUPIXENT.

CHECK COPAY CARD
ELIGIBILITY
* Subject to the program maximum per patient per calendar year. Approval is not guaranteed. THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs, including any state pharmaceutical assistance programs. This program is not valid where prohibited by law, taxed, or restricted. DUPIXENT MyWay reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Any savings provided by the program may vary depending on patients' out-of-pocket costs. The program is intended to help patients afford DUPIXENT. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms. Additional terms and conditions apply.

NEED ADDITIONAL
PATIENT SUPPORT?

The DUPIXENT MyWay patient program makes it easier to get supplemental injection training,
understand insurance coverage, and get help scheduling prescription deliveries.

Go to Patient Support